Published in N Engl J Med on May 24, 2001
In vivo multiphoton fluorescence lifetime imaging of protein-bound and free nicotinamide adenine dinucleotide in normal and precancerous epithelia. J Biomed Opt (2007) 2.09
Cost-effectiveness of a potential vaccine for human papillomavirus. Emerg Infect Dis (2003) 2.06
How can we develop a cost-effective quality cervical screening programme? Br J Gen Pract (2002) 1.44
New insights into cervical cancer screening. J Gynecol Oncol (2012) 0.92
The laboratory diagnosis of genital human papillomavirus infections. Can J Infect Dis Med Microbiol (2005) 0.89
Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia. Am J Obstet Gynecol (2011) 0.82
Antibody Therapeutics in Oncology. Immunotherapy (Los Angel) (2016) 0.75
Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med (2001) 13.07
Microbial water stress. Bacteriol Rev (1976) 5.80
Epidemiology of sexually transmitted Chlamydia trachomatis infections. Epidemiol Rev (1983) 4.85
Should we be measuring blood cholesterol levels in young adults? JAMA (1993) 3.57
Chlamydia trachomatis infections in the United States. What are they costing us? JAMA (1987) 3.32
Cost-effectiveness of a routine varicella vaccination program for US children. JAMA (1994) 3.27
The salt relations of marine and halophilic species of the unicellular green alga, Dunaliella. The role of glycerol as a compatible solute. Arch Mikrobiol (1974) 2.84
Water relations of sugar-tolerant yeasts: the role of intracellular polyols. J Gen Microbiol (1972) 2.77
The walls of the extremely halophilic cocci: gram-positive bacteria lacking muramic acid. J Gen Microbiol (1970) 2.55
Compatible solutes and extreme water stress in eukaryotic micro-organisms. Adv Microb Physiol (1978) 2.55
Objective and subjective assessments of socioeconomic status and their relationship to self-rated health in an ethnically diverse sample of pregnant women. Health Psychol (2000) 2.53
Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing. JAMA (1999) 2.33
Case mix, costs, and outcomes. Differences between faculty and community services in a university hospital. N Engl J Med (1984) 2.23
Appropriateness ratings: overuse, underuse, or misuse? Lancet (2001) 2.04
Cost-effectiveness of screening for carotid stenosis in asymptomatic persons. Ann Intern Med (1997) 1.93
Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. Health Econ (1997) 1.86
The new technology assessment. N Engl J Med (1990) 1.85
Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs. JAMA (1993) 1.84
Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol (2000) 1.82
Who should be offered prenatal diagnosis? The 35-year-old question. Am J Public Health (1999) 1.81
Cost-effectiveness of androgen suppression therapies in advanced prostate cancer. J Natl Cancer Inst (2000) 1.75
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med (1999) 1.73
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med (1999) 1.72
Prevalence and correlates of herpes simplex infections. The population-based AIDS in Multiethnic Neighborhoods Study. JAMA (1992) 1.71
Triglyceride concentration and coronary heart disease. BMJ (1994) 1.68
Developing and testing a multimedia presentation of a health-state description. Med Decis Making (1995) 1.68
Screening for hypertension. Ann Intern Med (1990) 1.68
Urodynamics of female incontinence: factors influencing the results of surgery. Am J Obstet Gynecol (1973) 1.67
Treatment of sexually transmitted chlamydial infections. JAMA (1986) 1.62
Functional, psychological, and satisfaction outcomes of laser in situ keratomileusis for high myopia. J Cataract Refract Surg (2000) 1.62
Cost-effectiveness of prenatal screening and immunization for hepatitis B virus. JAMA (1988) 1.60
Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences. Obstet Gynecol (2000) 1.58
Cost-effectiveness of culturing for Chlamydia trachomatis. A study in a clinic for sexually transmitted diseases. Ann Intern Med (1986) 1.57
Cost-effectiveness of automated external defibrillators on airlines. JAMA (2001) 1.52
Polymerase chain reaction for the diagnosis of HIV infection in adults. A meta-analysis with recommendations for clinical practice and study design. Ann Intern Med (1996) 1.50
The role of exercise testing in screening for coronary artery disease. Ann Intern Med (1989) 1.50
Using cost-effectiveness analysis to target cholesterol reduction. Ann Intern Med (2000) 1.45
Chilean women's preferences regarding mode of delivery: which do they prefer and why? BJOG (2006) 1.42
Microbial water relations: features of the intracellular composition of sugar-tolerant yeasts. J Bacteriol (1974) 1.37
Hospitalizations for pelvic inflammatory disease. Epidemiology and trends in the United States, 1975 to 1981. JAMA (1984) 1.32
Renal pharmacology of netilmicin. Antimicrob Agents Chemother (1977) 1.29
Estimation of the break-even point for smoking cessation programs in pregnancy. Am J Public Health (1992) 1.28
Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease. A word of caution about protection. JAMA (1985) 1.27
The economic cost of pelvic inflammatory disease. JAMA (1986) 1.24
Measurement of the validity of utility elicitations performed by computerized interview. Med Care (1997) 1.23
Citrate and glyoxylate cycles in the halophil, Halobacterium salinarium. Biochim Biophys Acta (1969) 1.23
A cost-based decision analysis for Chlamydia screening in California family planning clinics. Obstet Gynecol (1988) 1.22
Experience with various antibiotics for treatment of anorectal gonorrhea. Sex Transm Dis (1979) 1.21
The effect of assessment method and respondent population on utilities elicited for Gaucher disease. Qual Life Res (1997) 1.20
Pelvic inflammatory disease and its sequelae in adolescents. J Adolesc Health Care (1985) 1.17
An alternative method of isolating the membrane of a halophilic bacterium. J Gen Microbiol (1965) 1.17
The cost-effectiveness of prenatal carrier screening for cystic fibrosis. Obstet Gynecol (1994) 1.15
Properties of a halophil nicotinamide--adenine dinucleotide phosphate-specific isocitrate dehydrogenase. Preliminary studies of the salt relations and kinetics of the crude enzyme. Biochem J (1970) 1.13
An objective assessment of physiotherapy for female genuine stress incontinence. Br J Obstet Gynaecol (1987) 1.12
Racial-ethnic differences in prenatal diagnostic test use and outcomes: preferences, socioeconomics, or patient knowledge? Obstet Gynecol (1996) 1.11
The outer layer of the cell envelope of Halobacterium halobium. Can J Biochem (1969) 1.10
Ethnic differences in hormone replacement prescribing patterns. J Gen Intern Med (1999) 1.10
Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy. J Infect Dis (1993) 1.09
Vaginal douching as a possible risk factor for pelvic inflammatory disease. J Natl Med Assoc (1989) 1.09
Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model. JAMA (1991) 1.08
Water stress plating hypersensitivity of yeasts: protective role of trehalose in Saccharomyces cerevisiae. J Gen Microbiol (1988) 1.07
A basis of the specific sodium requirement for morphological integrity of Halobacterium halobium. Biochim Biophys Acta (1967) 1.07
A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol (1992) 1.06
Making the most of Pap testing. JAMA (1998) 1.05
Properties of halophil nicotinamide-adenine dinucleotide phosphate-specific isocitrate dehydrogenase. True Michaelis constants, reaction mechanisms and molecular weights. Biochem J (1972) 1.04
Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis. Obstet Gynecol (1996) 1.03
Water stress plating hypersensitivity of yeasts. J Gen Microbiol (1986) 1.01
Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis. Am J Public Health (1990) 1.01
Preferences of women facing a prenatal diagnostic choice: long-term outcomes matter most. Prenat Diagn (1999) 1.01
Alglucerase for Gaucher's disease: dose, costs and benefits. Pharmacoeconomics (1994) 0.98
Pelvic inflammatory disease. Key treatment issues and options. JAMA (1991) 0.98
The resting electrocardiogram as a screening test. A clinical analysis. Ann Intern Med (1989) 0.98
The membrane lipids of Halobacterium halobium. Biochem J (1968) 0.96
The salt relations of Dunaliella. Further observations on glycerol production and its regulation. Arch Microbiol (1977) 0.94
Anaerobes in pelvic inflammatory disease: implications for the Centers for Disease Control and Prevention's guidelines for treatment of sexually transmitted diseases. Clin Infect Dis (1999) 0.94
Selecting predictors of cancer patients' overall perceptions of the quality of care received. Ann Oncol (2005) 0.94
Quality of life assessment software for computer-inexperienced older adults: multimedia utility elicitation for activities of daily living. Proc AMIA Symp (2002) 0.93
Pelvic inflammatory disease. A brief overview. Ann Epidemiol (1994) 0.91
Sedimentation, viscosity and partial specific volumes of membrane proteins and lipoproteins. Biochem J (1967) 0.91
Can preference scores for discrete states be used to derive preference scores for an entire path of events? An application to prenatal diagnosis. Med Decis Making (1997) 0.90
Inhibitory effect of captopril on renal responses to frusemide in sodium-restricted rats. J Pharm Pharmacol (1984) 0.90
Prevalence, incidence, and correlates of syphilis seroreactivity in multiethnic San Francisco neighborhoods. Ann Epidemiol (1994) 0.90
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 6. Cost effectiveness of assessment and management of risk factors. J Am Coll Cardiol (1996) 0.89
Antibiotic treatment of pelvic inflammatory disease. Trends among private physicians in the United States, 1966 through 1983. JAMA (1986) 0.87
Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems. Proc AMIA Annu Fall Symp (1997) 0.86
Microbial water relations. Effects of solute concentration on the respiratory activity of sugar-tolerant and non-tolerant yeasts. J Gen Microbiol (1975) 0.86
Hormone replacement therapy for African American women: missed opportunities for effective intervention. Menopause (1999) 0.86
Safety and predictability of laser in situ keratomileusis enhancement by flap reelevation in high myopia. J Cataract Refract Surg (2001) 0.86
Problems with the report of the Expert Panel on blood cholesterol levels in children and adolescents. Arch Pediatr Adolesc Med (1995) 0.86
Organizational strategies to tackle health-care disparities in the USA. Health Serv Manage Res (2006) 0.85
Cost of ectopic pregnancy management: surgery versus methotrexate. Fertil Steril (1993) 0.85
Multimedia quality of life assessment: advances with FLAIR. AMIA Annu Symp Proc (2005) 0.84
Regulation of adrenergic receptor number following chronic noradrenaline infusion in the rabbit. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.83
Triglyceride concentration and coronary heart disease. BMJ (1994) 0.83
Preliminary fractionation by gel electrophoresis of the membrane proteins and lipoproteins of Halobacterium halobium. Can J Biochem (1969) 0.82
Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women. Br J Obstet Gynaecol (1987) 0.82
Cervical cancer screening: which techniques should be used and why? Clin Obstet Gynecol (1999) 0.82
Cost-effectiveness of combined treatment for endocervical gonorrhea. Considering co-infection with Chlamydia trachomatis. JAMA (1987) 0.81
Quantifying female incontinence with particular reference to the Urilos System. Urol Int (1980) 0.81
Preterm delivery in patients admitted with preterm labor: a prediction study. J Matern Fetal Med (2001) 0.81